awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q36023385-F671DFFE-5BD9-4265-BD3A-4E471ECBF957
Q36023385-F671DFFE-5BD9-4265-BD3A-4E471ECBF957
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36023385-F671DFFE-5BD9-4265-BD3A-4E471ECBF957
Long-term changes in cardiovascular risk markers during administration of exenatide twice daily or glimepiride: results from the European exenatide study.
P2860
Q36023385-F671DFFE-5BD9-4265-BD3A-4E471ECBF957
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36023385-F671DFFE-5BD9-4265-BD3A-4E471ECBF957
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
43dd232e8b13fd6763930747a5c0b022adb51839
P2860
Vildagliptin add-on to metformin produces similar efficacy and reduced hypoglycaemic risk compared with glimepiride, with no weight gain: results from a 2-year study.